시장보고서
상품코드
1605699

커넥티드 약물전달 기기 시장 : 제품 유형별, 용도별, 투여 경로별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Connected Drug Delivery Devices Market, By Product Type, By Application, Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 388 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

커넥티드 약물전달 기기 시장 규모는 2023년 5조 1,234억 5,000만 달러로 2024년부터 2032년까지 연평균 23.5%의 성장률을 기록할 것으로 예상됩니다.

커넥티드 약물전달 기기 시장 : 시장 역학

스마트하고 효율적인 약물전달 솔루션에 대한 수요 증가

당뇨병, 천식 등 만성질환의 증가로 인해 커넥티드 약물전달 기기에 대한 수요가 증가하고 있습니다. 이러한 장치는 디지털 플랫폼을 통해 실시간 모니터링, 알림, 피드백을 제공함으로써 환자의 복약 순응도를 향상시킬 수 있습니다. 맞춤형 의료에 대한 인식이 높아지고 의료에 IoT가 통합되면서 이러한 기기의 채택이 더욱 가속화되고 있습니다. 무선 연결 및 모바일 애플리케이션과 같은 기술 발전은 의료 전문가의 원격 모니터링을 가능하게함으로써 치료 결과를 향상시킬 수 있습니다. 또한, 스마트 의료 솔루션에 대한 투자 확대와 재택 의료의 활성화는 효과적이고 효율적인 약물 투여 시스템에 대한 전 세계 수요를 충족시키며 시장을 활성화시키고 있습니다.

커넥티드 약물전달 기기 시장 : 주요 고려 사항

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 23.5%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 통합형 디바이스 부문이 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

용도별로는 2023년 당뇨병 부문이 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 매출 1위

커넥티드 약물전달 기기 시장 : 세분화 분석

세계 커넥티드 약물전달 기기 시장은 제품 유형, 응용 분야, 투여 경로, 지역에 따라 세분화됩니다. 제품 유형에 따라 시장은 독립형 컴포넌트, 소프트웨어 및 통합 장치 등 세 가지로 나뉩니다. 커넥티드 약물전달 시장을 주도하고 있는 것은 통합 장치 분야입니다. 이러한 장치는 약물전달 메커니즘과 내장된 연결 기능을 결합하여 실시간으로 원활한 추적, 모니터링 및 데이터 공유를 가능하게 합니다. 편의성, 환자의 복약 순응도 향상, 디지털 의료 시스템과의 통합 기능 등이 이 장치의 보급을 촉진하는 원동력이 되고 있습니다. 개인화되고 효율적인 약물 투여에 대한 수요가 증가함에 따라, 통합형 디바이스는 특히 당뇨병, 천식 등 만성질환 관리에 있어 의료진과 환자들 사이에서 선호되는 선택이 되고 있습니다.

투여 경로별(비경구, 흡입) : 커넥티드 약물전달 기기 시장은 비경구 투여 부문이 주도하고 있습니다. 당뇨병과 같은 만성질환의 높은 유병률과 커넥티드 인슐린 펜과 같은 자가 투약 장치의 채택 증가가 이 부문의 우위를 견인하고 있습니다. 비경구 투여 장치는 정확한 투약, 사용 편의성, 실시간 데이터 추적을 통한 환자 순응도 향상 등의 이점을 제공합니다. 또한, 주사 기반 전달이 필요한 생물학적 제제의 증가는 커넥티드 비경구용 기기에 대한 수요를 더욱 증가시켜 시장에서의 선도적 지위를 더욱 공고히 하고 있습니다.

용도별(천식, COPD, 당뇨병 관리, 기타(자가면역질환, 다발성 경화증 등)) : 당뇨병 관리 분야가 커넥티드 약물전달 기기 시장을 주도하고 있습니다. 이는 전 세계 당뇨병 유병률의 증가와 스마트 인슐린 펜 및 혈당 모니터링 시스템의 채택 증가에 기인합니다. 이러한 장치는 치료 계획 준수율을 높이고, 실시간 모니터링 및 데이터 공유 기능을 제공하여 환자의 치료 결과를 개선할 수 있도록 돕습니다. 디지털 헬스 기술에 대한 투자가 확대되고 맞춤형 의료에 대한 관심이 높아짐에 따라, 당뇨병 관리 분야는 계속해서 시장 수요의 대부분을 주도하고 있습니다.

커넥티드 약물전달 기기 시장 : 지역별 분석

연결형 약물전달 기기 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카에서 강력한 성장세를 보이고 있습니다. 북미는 선진화된 의료 인프라, 높은 디지털 헬스 솔루션 도입률, 당뇨병, 천식 등 만성질환 환자 수가 많아 시장을 주도하고 있습니다. 유럽은 의료 디지털화에 많은 투자를 하고 있으며, 노인 인구가 증가하고 있습니다. 반면, 아시아태평양은 의료 투자 증가, 스마트폰 사용률 증가, 커넥티드 디바이스에 대한 접근성 확대로 인해 빠른 성장세를 보이고 있습니다. 라틴아메리카와 중동 및 아프리카의 신흥국들도 의료 접근성 향상으로 잠재력을 발휘하고 있습니다.

커넥티드 약물전달 기기 시장 : 경쟁 구도

약물전달 기기 시장은 경쟁이 치열하고 주요 기업들이 혁신과 전략적 제휴에 집중하고 있으며, Propeller Health, Phillips-Medisize, Teva Pharmaceuticals, Adherium과 같은 기업들은 스마트 기술을 활용하여 환자 순응도 및 모니터링을 강화하고 있습니다. 환자 순응도 및 모니터링을 강화하기 위해 스마트 기술을 활용하고 있습니다. 제약회사와 하이테크 기업의 제휴는 첨단 기기 개발을 촉진하고 있습니다. 스타트업들도 AI 기반 솔루션으로 시장에 진입하면서 경쟁이 치열해지고 있습니다. 또한, 각 업체들은 규제 요건을 충족하고 사용 편의성을 개선하기 위해 연구개발에 투자하고 있습니다. 만성질환 관리에 커넥티드 디바이스가 도입되면서 이 역동적인 시장에서의 경쟁은 더욱 가속화되고 있습니다.

목차

제1장 커넥티드 약물전달 기기 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 커넥티드 약물전달 기기의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 커넥티드 약물전달 기기 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체제 분석

제5장 커넥티드 약물전달 기기 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 커넥티드 약물전달 기기 시장 상황

  • 커넥티드 약물전달 기기 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 커넥티드 약물전달 기기 시장 : 제품 종류별

  • 개요
    • 부문 점유율 분석 : 제품 종류별
    • 독립형 컴포넌트
    • 소프트웨어·통합 디바이스

제8장 커넥티드 약물전달 기기 시장 : 용도별

  • 개요
    • 부문 점유율 분석 : 용도별
    • 만성폐쇄성폐질환
    • 당뇨병 관리
    • 기타(자가면역질환, 다발성 경화증 등)

제9장 커넥티드 약물전달 기기 시장 : 투여 경로별

  • 개요
    • 부문 점유율 분석 : 투여 경로별
    • 비경구
    • 흡입

제10장 커넥티드 약물전달 기기 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 커넥티드 약물전달 기기 업계

  • 경쟁 대시보드
    • 경쟁 벤치마크
    • 경쟁 포지셔닝
  • 기업 개요
    • Phillips-Medisize(a Molex company)
    • BD(Becton, Dickinson and Company)
    • West Pharmaceutical Services, Inc.
    • Ypsomed AG
    • Novo Nordisk A/S
    • Propeller Health(a ResMed company)
    • Adherium Limited
    • Sensirion AG
    • Cohero Health(a Teva Pharmaceuticals subsidiary)
    • AptarGroup, Inc.
    • Others

제12장 AnalystView 전방위적 분석

ksm 24.12.16

REPORT HIGHLIGHT

Connected Drug Delivery Devices Market size was valued at USD 5,123.45 Billion in 2023, expanding at a CAGR of 23.5% from 2024 to 2032.

Connected drug delivery devices integrate advanced digital technology with traditional drug delivery systems to enhance patient care. These devices enable real-time monitoring, data sharing, and adherence tracking, offering personalized treatment options. Commonly used in chronic disease management, they support conditions like diabetes, asthma, and cardiovascular disorders. With features such as Bluetooth connectivity and smartphone integration, connected drug delivery devices improve therapeutic outcomes while empowering patients and healthcare providers with actionable insights for better disease management.

Connected Drug Delivery Devices Market- Market Dynamics

Increasing Demand for Smart and Efficient Drug Delivery Solutions

The increasing prevalence of chronic diseases, such as diabetes and asthma, is driving demand for connected drug delivery devices. These devices enhance patient adherence by providing real-time monitoring, reminders, and feedback through digital platforms. Rising awareness about personalized medicine and the integration of IoT in healthcare are further boosting their adoption. Technological advancements, including wireless connectivity and mobile applications, improve treatment outcomes by enabling remote monitoring for healthcare professionals. Additionally, growing investments in smart healthcare solutions and the push for home-based care are fueling the market, addressing the need for effective and efficient drug administration systems globally.

Connected Drug Delivery Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2024-2032)

Based on Product Type segmentation, the integrated devices segment was predicted to show maximum market share in the year 2023

Based on application segmentation, the diabetes segment was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Connected Drug Delivery Devices Market- Segmentation Analysis:

The Global Connected Drug Delivery Devices Market is segmented based on Product Type, Application, Route of Administration, and Region. The market is divided into three categories based on Product Type: Standalone Components & Software and Integrated Devices. The Integrated Devices segment dominates the Connected Drug Delivery Devices Market. These devices combine drug delivery mechanisms with built-in connectivity features, enabling seamless tracking, monitoring, and data sharing in real-time. Their convenience, improved patient adherence, and ability to integrate into digital healthcare systems have driven widespread adoption. With the growing demand for personalized and efficient drug administration, integrated devices are becoming the preferred choice among healthcare providers and patients, particularly in managing chronic conditions like diabetes and asthma.

Based on route of administration: Parenteral and Inhalational. The parenteral segment dominates the Connected Drug Delivery Devices Market. The high prevalence of chronic diseases like diabetes and the increasing adoption of self-administration devices such as connected insulin pens drive this dominance. Parenteral devices offer precise dosing, ease of use, and enhanced patient compliance through real-time data tracking. Additionally, the rise in biologics requiring injection-based delivery further boosts demand for connected parenteral devices, solidifying their leading position in the market.

By application: Asthma, COPD, Diabetes Management and Others (autoimmune diseases, multiple sclerosis, etc.). The Diabetes Management segment dominates the Connected Drug Delivery Devices Market. This is attributed to the rising prevalence of diabetes globally and the increasing adoption of smart insulin pens and glucose monitoring systems. These devices offer improved adherence to treatment plans, real-time monitoring, and data sharing capabilities, enhancing patient outcomes. With growing investments in digital health technologies and a focus on personalized care, diabetes management continues to drive the majority of the demand in this market.

Connected Drug Delivery Devices Market- Geographical Insights

The Connected Drug Delivery Devices Market shows strong growth across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads due to its advanced healthcare infrastructure, high adoption rates of digital health solutions, and a large patient base for chronic conditions like diabetes and asthma. Europe follows with significant investments in healthcare digitalization and a growing elderly population. Meanwhile, Asia-Pacific exhibits rapid growth driven by increasing healthcare investments, rising smartphone usage, and expanding access to connected devices. Emerging economies in Latin America and the Middle East & Africa also display potential due to improving healthcare access.

Connected Drug Delivery Devices Market- Competitive Landscape:

The Connected Drug Delivery Devices Market is highly competitive, with key players focusing on innovation and strategic collaborations. Companies such as Propeller Health, Phillips-Medisize, Teva Pharmaceuticals, and Adherium are leveraging smart technology to enhance patient adherence and monitoring. Partnerships between pharmaceutical firms and tech companies are driving the development of advanced devices. Startups are also entering the market with AI-enabled solutions, intensifying competition. Additionally, players are investing in R&D to meet regulatory requirements and improve usability. The adoption of connected devices in managing chronic diseases is further accelerating competition in this dynamic market.

Recent Developments:

In February 2022, AptarGroup Inc. introduced the HeroTracker Sense, a digital solution that transforms traditional metered-dose inhalers into smart devices for enhanced medication management, particularly for asthma and COPD patients. This tool integrates with the BreatheSmart app, improving adherence and disease management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Phillips-Medisize (a Molex company)
  • BD (Becton, Dickinson and Company)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Novo Nordisk A/S
  • Propeller Health (a ResMed company)
  • Adherium Limited
  • Sensirion AG
  • Cohero Health (a Teva Pharmaceuticals subsidiary)
  • AptarGroup, Inc.
  • Others

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Standalone Components
  • Software and Integrated Devices

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Asthma
  • COPD
  • Diabetes Management
  • Others (autoimmune diseases, multiple sclerosis, etc.)

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Parenteral
  • Inhalational

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Connected Drug Delivery Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Connected Drug Delivery Devices Market Snippet by Product Type
    • 2.1.2. Connected Drug Delivery Devices Market Snippet by Application
    • 2.1.3. Connected Drug Delivery Devices Market Snippet by Route of Administration
    • 2.1.4. Connected Drug Delivery Devices Market Snippet by Country
    • 2.1.5. Connected Drug Delivery Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Connected Drug Delivery Devices Key Market Trends

  • 3.1. Connected Drug Delivery Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Connected Drug Delivery Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Connected Drug Delivery Devices Market Opportunities
  • 3.4. Connected Drug Delivery Devices Market Future Trends

4. Connected Drug Delivery Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Connected Drug Delivery Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Connected Drug Delivery Devices Market Landscape

  • 6.1. Connected Drug Delivery Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Connected Drug Delivery Devices Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Standalone Components
    • 7.1.3. Software and Integrated Devices

8. Connected Drug Delivery Devices Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. COPD
    • 8.1.3. Diabetes Management
    • 8.1.4. Others (autoimmune diseases, multiple sclerosis, etc.)

9. Connected Drug Delivery Devices Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Parenteral
    • 9.1.3. Inhalational

10. Connected Drug Delivery Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Connected Drug Delivery Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Connected Drug Delivery Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Connected Drug Delivery Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Connected Drug Delivery Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Connected Drug Delivery Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Connected Drug Delivery Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Phillips-Medisize (a Molex company)
    • 11.2.2. BD (Becton, Dickinson and Company)
    • 11.2.3. West Pharmaceutical Services, Inc.
    • 11.2.4. Ypsomed AG
    • 11.2.5. Novo Nordisk A/S
    • 11.2.6. Propeller Health (a ResMed company)
    • 11.2.7. Adherium Limited
    • 11.2.8. Sensirion AG
    • 11.2.9. Cohero Health (a Teva Pharmaceuticals subsidiary)
    • 11.2.10. AptarGroup, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제